Information about the distribution of biopharmaceuticals is basic for understanding their actions. Tissue and cellular localization is a key to function. Autoradiography with radiolabeled compounds has provided valuable information with both low resolution whole-body macro-autoradiography and high resolution microscopic autoradiography (micro-autoradiography). Whole-body macro-autoradiography is a uniform and expedient single method approach, providing convenient dose- and time-related overviews with data similar to those obtained with conventional bioassays - and therefore widely used. However, whole-body macro-autoradiography, like common bioassays, has limitations. High specificity-low capacity sites of binding and deposition frequently remain unrecognized. Lack of cellular resolution can cause false negatives and provide misleading results (e.g., false blood-brain barrier). For micro-autoradiography, different methods are advertised in the literature. Most of them are, however, unsuited for drug localization because of inadequate resolution and frequent artifacts. Most drugs interact with their receptors non-covalently by weak electrostatic forces. Therefore, translocation and loss can occur during tissue preparation. This has complicated the use of micro-autoradiography. Receptor micro-autoradiography has overcome these complications and is a method of choice. It has been validated through several diffusible compounds with known localization, extensively applied. It has contributed numerous discoveries, followed by new concepts and therapies. Pictorial evidence in this review indicates that cellular information is essential, a 'sine qua non' for meaningful drug distribution studies. High resolution cellular microscopic information obtained from autoradiography requires tissue dissection and the necessary precautions for preserving pristine in vivo drug deposition. Receptor micro-autoradiography fulfils these requirements. It reveals crucial information at the subcellular level that cannot currently be obtained with any other type of autoradiography or spectrometric imaging.

译文

:有关生物药物分布的信息是了解其作用的基础。组织和细胞定位是功能的关键。放射标记化合物的放射自显影技术提供了有价值的信息,包括低分辨率全身宏观放射自显影技术和高分辨率显微放射自显影技术(微放射自显影技术)。全身宏观放射自显影术是一种统一且便捷的单一方法,可提供与剂量和时间相关的便捷概览,其数据类似于通过常规生物测定获得的数据,因此得到了广泛的应用。但是,全身宏观放射自显影像常规生物测定法一样有局限性。结合和沉积的高特异性低容量位点经常未被识别。缺乏细胞分辨率会导致假阴性,并产生误导性的结果(例如,虚假的血脑屏障)。对于微放射自显影,在文献中宣传了不同的方法。然而,由于分辨率不足和伪影频发,它们中的大多数不适合药物定位。大多数药物通过弱的静电力与其受体非共价地相互作用。因此,在组织制备过程中会发生移位和丢失。这使微放射自显影的使用变得复杂。受体微放射自显影技术克服了这些并发症,是一种选择方法。它已通过多种具有已知局域性且广泛应用的可扩散化合物进行了验证。它做出了许多发现,随后又提出了新的概念和疗法。这篇评论中的图形证据表明,细胞信息是必不可少的,对于有意义的药物分布研究而言,这是“必要条件”。从放射自显影技术获得的高分辨率细胞显微信息需要进行组织解剖,并需要采取必要的预防措施来保存原始的体内药物沉积。受体微放射自显影可以满足这些要求。它揭示了亚细胞水平上的关键信息,这些信息目前无法通过任何其他类型的放射自显影或光谱成像获得。

+1
+2
100研值 100研值 ¥99课程
检索文献一次
下载文献一次

去下载>

成功解锁2个技能,为你点赞

《SCI写作十大必备语法》
解决你的SCI语法难题!

技能熟练度+1

视频课《玩转文献检索》
让你成为检索达人!

恭喜完成新手挑战

手机微信扫一扫,添加好友领取

免费领《Endnote文献管理工具+教程》

微信扫码, 免费领取

手机登录

获取验证码
登录